Covered recipient · General Payments record
LIESHE C SEVEREIN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,303.03
- Reported across 73 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $482.22 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $249.04 | 8 |
| EISAI INC. | $53.97 | 2 |
| Alexion Pharmaceuticals, Inc. | $44.59 | 2 |
| Exact Sciences Corporation | $30.52 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $25.47 | 1 |
| IBSA Pharma Inc. | $23.27 | 1 |
| Amgen Inc. | $19.50 | 1 |
| Novo Nordisk AS | $19.03 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $16.83 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $30.00 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108175624 | CMS |
| ABBVIE INC. | $22.24 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108175626 | CMS |
| ABBVIE INC. | $15.97 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108175628 | CMS |
| ABBVIE INC. | $10.75 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108175630 | CMS |
| ABBVIE INC. | $16.02 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108175632 | CMS |
| ABBVIE INC. | $118.07 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108175634 | CMS |
| ABBVIE INC. | $32.08 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108175636 | CMS |
| ABBVIE INC. | $3.91 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108175638 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $16.83 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146972709 | CMS |
| Alexion Pharmaceuticals, Inc. | $24.45 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1094020224 | CMS |
| Alexion Pharmaceuticals, Inc. | $20.14 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093894044 | CMS |
| Amgen Inc. | $19.50 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117680240 | CMS |
| Eisai Inc. | $20.26 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110811812 | CMS |
| Eisai Inc. | $33.71 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110811810 | CMS |
| Exact Sciences Corporation | $30.52 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114434685 | CMS |
| IBSA Pharma Inc. | $23.27 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142987230 | CMS |
| Novo Nordisk Inc | $19.03 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100365071 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $25.47 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153524413 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.